Search - tctmd.com

Displaying 81 - 100 of 102

Sort: Relevancy | Date

News Industry News

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

October 28, 2013

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Conference News ESC 2013

CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis

Yael L. Maxwell

September 03, 2013

News Industry News

FDA Accepts the Filing of The Medicines Company's New Drug Application for Intravenous Antiplatelet Agent Cangrelor

July 01, 2013

News Opinion Conversations in Cardiology

Conversations in Cardiology: Plavix and PPI

June 28, 2013

News Opinion Conversations in Cardiology

Conversations in Cardiology: Bridging Antithrombotic Therapy Between PCI & CABG

June 03, 2013

News Conference News ACC 2013

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

L.A. McKeown

March 14, 2013

News Conference News ACC 2013

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

Yael L. Maxwell

March 09, 2013

News Daily News

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

L.A. McKeown

December 05, 2012

News Daily News

Prasugrel y Ticagrelor Retrasan la Acción Antiplaquetaria en Pacientes Víctimas de un STEMI

L.A. McKeown

December 05, 2012

Presentation TCT 2012

Cangrelor: CHAMPION PHOENIX Update

Presenter: Harvey White

October 24, 2012

News Daily News

Universal Definition of MI Shifts Advantage Toward Cangrelor in PCI

Caitlin E. Cox

March 20, 2012

News Daily News

La Definición Universal de IM se Posiciona en Favor del Cangrelor en las PCI

Caitlin E. Cox

March 20, 2012

Presentation

Reduced Immediate Ischemic Events with Cangrelor in PCI: Pooled Analysis of the CHAMPION Trials Using the Universal Definition of MI

Presenter: 35236|Harvey White

March 16, 2012

Presentation

Menores Episodios Isquémicos Inmediatos con el Cangrelor en las PCI: Análisis Conjunto de los Ensayos Champion usando la Definición Universal de IM

Presenter: Harvey D. White

March 16, 2012

Presentation

Puenteando la Terapia Antiplaquetaria con Cangrelor en Pacientes que se someten a Cirugía Cardíaca

Presenter: Dominick J. Angiolillo

January 16, 2012

Presentation

Bridging Antiplatelet Therapy with Cangrelor in Patients Undergoing Cardiac Surgery

Presenter: Dominick J. Angiolillo

January 16, 2012

News Daily News

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

January 16, 2012

News Conference News

BRIDGE: Cangrelor Provides Effective Maintenance of Platelet Inhibition Without Major Bleeding

November 09, 2011

News Industry News

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

November 08, 2011

Advertisement

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis

FDA Accepts the Filing of The Medicines Company's New Drug Application for Intravenous Antiplatelet Agent Cangrelor

Conversations in Cardiology: Plavix and PPI

Conversations in Cardiology: Bridging Antithrombotic Therapy Between PCI & CABG

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

Prasugrel y Ticagrelor Retrasan la Acción Antiplaquetaria en Pacientes Víctimas de un STEMI

Cangrelor: CHAMPION PHOENIX Update

Universal Definition of MI Shifts Advantage Toward Cangrelor in PCI

La Definición Universal de IM se Posiciona en Favor del Cangrelor en las PCI

Reduced Immediate Ischemic Events with Cangrelor in PCI: Pooled Analysis of the CHAMPION Trials Using the Universal Definition of MI

Menores Episodios Isquémicos Inmediatos con el Cangrelor en las PCI: Análisis Conjunto de los Ensayos Champion usando la Definición Universal de IM

Puenteando la Terapia Antiplaquetaria con Cangrelor en Pacientes que se someten a Cirugía Cardíaca

Bridging Antiplatelet Therapy with Cangrelor in Patients Undergoing Cardiac Surgery

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

BRIDGE: Cangrelor Provides Effective Maintenance of Platelet Inhibition Without Major Bleeding

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content